Evaluation of microparticle leakage during DALI LDL adsorption in a simulated clinical setting

International Journal of Artificial Organs

Volumn 23, Issue 5, 2000, Pages 338-344

  Heinemann, O ^a   Bosch, T ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

DALI; LDL hemoperfusion; Microparticles; Particle leakage

Indexed keywords

MEDICINE;

ADSORBERS; CLINICAL SETTINGS; CLINICAL SITUATIONS; CONDITION; DALI; HEMOPERFUSION; LDL-HEMOPERFUSION; MICRO PARTICLES; PARTICLE LEAKAGE; PARTICLE RELEASE;

ADSORPTION;

LOW DENSITY LIPOPROTEIN;

APHERESIS; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; EXTRACORPOREAL CIRCULATION; HEMOPERFUSION; HUMAN; SIMULATION;

EID: 0034086109     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880002300509     Document Type: Article

References (14)

1. Bosch T, Schmidt B, Kleophas W, et al. LDL Hemoperfusion -a new procedure for LDL apheresis: first clinical application of an LDL adsorber compatible with human whole blood. Int J Artif Organs 1997; 21: 977-82.
2. Bosch T, Lennertz A, Schmidt B, et al. Direct adsorption of lipoproteins from whole blood by DALI apheresis: clinical efficacy and biocompatibility. Int J Artif Organs 1998; 21: 611.
3. Dräger LJ, Julius U, Kraenzle K, et al. DALI - the first human whole blood low-density lipoprotein and lipoprotein (a) apheresis system in clinical use: procedure and clinical results. Eur J Clin Invest 1998; 28: 994-1002.
4. Bosch T, Schenzle D, Dräger J for the DALI study group. Direct adsorption of LDL and Lp (a) from whole blood: results of the first clinical long-term study using DALI. Atherosclerosis 1999; 144 (suppl. 1): S23.
5. Inoue K, Bambauer R. Evaluation of microparticles released from an adsorber used for low-density lipoprotein apheresis. ASAIO J 1998; 44: M470-4.
6. Otto V, Schön A. Results of the last 11 production lots of DALI adsorber kits. ASAIO J 1999; 45: 115-6.
7. Otto V, Schön A. Letter on: Evaluation of microparticles released from an adsorber used for low density lipoprotein apheresis. ASAIO J 1999; 45: 234.
8. Bundesministerium für Gesundheit, ed. Hämofiltrationslösungen. In: Europäisches Arzneibuch. Stuttgart: Deutscher Apotheker Verlag, 1997; 1015-7.
9. British Pharmacopoeia Commission Secretary, ed. Limit test for particulate matter. In: British Pharmacopoeia. London: HMSO; 1993; 748 and Appendix XIII; A163.
10. The United States Pharmacopeial Convention Inc, ed. Particulate matter in injections. In: United States Pharmacopeia Taunton: Rand McNally; 1995; 1652 and 1813-16.
11. Hoenich NA, Thompson J, McCabe J, Appleton DR. Particle release from haemodialysers. Int J Artif Organs 1990; 13: 803-8.
12. Briceno JC, Runge TM. Tubing spallation in extracorporeal circuits. An in vivo study using an electronic particle counter. Int J Artif Organs 1992; 15: 222-8.
13. Bain R, Abethell JA. The particulate contribution from infusion devices. Br J Pharmaceut Pract 1988; 13: 42-8.
14. nd International Congress of the International Society for Apheresis, Saarbrücken, Germany, April 15-18, 1999; 123.